ViaDerma Announces Significant 2024 Achievements and International Expansion
10. Dezember 2024 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Dec. 10, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM), an innovator in transdermal drug delivery and topical antibiotic products, proudly announces the completion of a...
ViaDerma, Inc. Reports Strong Financial Results for Q2 2024, Achieving Positive Net Income and Significant Cash Flow Growth
03. Oktober 2024 08:00 ET
|
ViaDerma, Inc.
ViaDerma post strong Q2 results
ViaDerma Completes First Shipment of 500,000 Units to Nigeria
10. September 2024 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a specialty pharmaceutical company known for developing innovative transdermal drug delivery systems, is pleased to...
ViaDerma Announces Shipment of 500,000 Units of its Flagship Product to Nigeria
13. August 2024 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Aug. 13, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC: VDRM), a leader in innovative wound care solutions, is excited to announce that a shipment of 500,000 units of its flagship...
ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires
01. August 2024 08:00 ET
|
ViaDerma, Inc.
ViaDerma announces strategic new agreements to move forward its global expansion.
ViaDerma Provides Highlights of Quarterly Financial Report
06. Juni 2024 08:00 ET
|
ViaDerma, Inc.
ViaDerma provides an update on their most recent quarterly financial report
ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More
24. Oktober 2023 10:30 ET
|
ViaDerma, Inc.
LOS ANGELES, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce several new and exciting business updates for current and prospective shareholders,...
ViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & More
06. Juli 2023 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, July 06, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is very pleased to announce several exciting business updates for current and prospective shareholders, partners, and...
ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product
16. März 2023 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, March 16, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce that the company has recently submitted their application for their planned minoxidil hair...
ViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth Product
08. März 2023 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, March 08, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce their plans to launch a new hair regrowth product using Minoxidil (topical route). The company...